Definium Therapeutics Inc. Common Shares vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.32 (market cap $4.59B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22.17 (market cap $249.48B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 54.4× Definium Therapeutics Inc. Common Shares's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days on average.
| DFTX | MUFG | |
|---|---|---|
Market Cap | $4.59B | $249.48B |
Volume | 2,103,937 | 4,008,160 |
Sector | Health | Financials |
52-Week High | $48.45 | $24.13 |
52-Week Low | $10.68 | $14.62 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $28.96T |
Dividend Yield | — | 2.4% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →